NCI May ' Kill ' Major Mammography Trial, Says Advisor NCI May ' Kill ' Major Mammography Trial, Says Advisor

An advisory group to the National Cancer Institute is reviewing the"feasibility and relevance" of the ongoing TMIST trial that is comparing 3-D to 2-D mammography and is asking if it should continue.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news